Biomarin Pharmaceuticals (NQ: BMRN )
82.52
-0.46
(-0.55%)
Streaming Delayed Price
Updated: 11:22 AM EDT, Jul 10, 2024
Add to My Watchlist
Headline News about Biomarin Pharmaceuticals![]() ![]() Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() ![]()
FDA Slaps Clinical Hold on BioMarin's Gene Therapy For Genetic Metabolism Disorder
September 07, 2021
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() Via Talk Markets
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]()
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
April 24, 2021
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|